Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Handling hormone replacement therapy: key issues for the prescriber

J C Stevenson1

  • 1Wynn Division of Metabolic Medicine, National Heart and Lung Institute, Imperial College, London, UK.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|April 1, 1996
PubMed
Summary

Physicians should consider various hormone replacement therapy (HRT) routes, including oral, transdermal, and implants, balancing efficacy, patient preference, and clinical factors like cardiovascular risk for optimal menopause management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hormone replacement therapy on intervertebral disc height.

Climacteric : the journal of the International Menopause Society·2023
Same author

Cardiometabolic health in premature ovarian insufficiency.

Climacteric : the journal of the International Menopause Society·2021
Same author

HRT and breast cancer: a million women ride again.

Climacteric : the journal of the International Menopause Society·2020
Same author

The menopausal hot flush: a review.

Climacteric : the journal of the International Menopause Society·2017
Same author

Cardiovascular risk assessment in women - an update.

Climacteric : the journal of the International Menopause Society·2016
Same author

Bisphosphonate drug holidays--when, why and for how long?

Climacteric : the journal of the International Menopause Society·2015

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
  • Different routes of administration for HRT exist, each with unique pharmacokinetic profiles.
  • The choice of HRT impacts various health outcomes, including bone health and cardiovascular risk factors.

Purpose of the Study:

  • To outline key considerations for physicians prescribing hormone replacement therapy (HRT).
  • To compare the effectiveness and side-effect profiles of different HRT administration routes.
  • To emphasize the importance of patient-centered care in HRT selection.

Main Methods:

  • Literature review including published and unpublished data.
  • Analysis of pharmacokinetic differences between oral and non-oral HRT formulations.

Related Experiment Videos

  • Evaluation of HRT effects on osteoporosis and cardiovascular disease risk factors.

    • Main Results:

    • Oral HRT may require higher doses due to first-pass liver metabolism; alternatives include gels, pessaries, implants, and patches.
    • Transdermal estrogen delivery offers accurate dosing and is perceived as more 'natural' by patients.
    • All HRT routes are equally effective for osteoporosis prevention with equivalent doses; cardiovascular effects vary, with oral HRT potentially impacting glucose metabolism more than transdermal.
    • Progestogen side-effects are common, but a variety of options allows for switching if needed.

    Conclusions:

    • Route selection for HRT depends on patient's clinical status (e.g., triglycerides) and preference, which is crucial for compliance.
    • Fixed combinations of estrogen and progestogen can improve adherence.
    • Patient satisfaction is the ultimate determinant of successful HRT management.